Biosig Technologies Inc. is on a hot streak this week. In addition to reporting the close of a private placement of almost $4.3 million, the company said it had scored 510(k) clearance from the FDA for its first product, the Pure EP system. The noninvasive system is designed to help electrophysiologists make decisions during procedures to diagnose and treat patients with abnormal heart rates and rhythms.